在埃塞俄比亚西北部巴希尔达尔 (Bahir Dar) 的卫生专业人员中探索危险的酒精使用及其决定因素
Selam Koye1, Techilo Tinsae1, Melak Menberu2
1Department of Psychiatry College of Medicine and Health Science, University of Gondar, Gondar, Ethiopia.
Frontiers in psychiatry
|March 7, 2025
概括
危险的酒精使用影响到埃塞俄比亚16.4%的卫生专业人员. 家庭病史,心理困扰,Khat使用和文凭教育是显著的风险因素,需要有针对性的干预.
科学领域:
- 公共卫生 公共卫生
- 流行病学 流行病学
- 药物滥用研究 药物滥用研究
背景情况:
- 卫生专业人员的酒精消费对个人及其职业职责构成重大风险.
- 关于埃塞俄比亚卫生专业人员中危险酒精使用的流行率和决定因素的研究有限.
研究的目的:
- 为了确定埃塞俄比亚巴希尔市卫生专业人员中危险酒精使用的程度.
- 为了确定与该人口中危险的酒精使用相关的因素.
主要方法:
- 对384名卫生专业人员进行了一项基于机构的横截面研究.
- 数据采集使用自我管理的问卷,包括酒精使用障碍识别测试 (AUDIT).
- 使用双变量和多变量逻辑回归分析来确定重要的决定因素.
主要成果:
- 危险饮酒的患病率为16.4% (95% CI:13% - 20.3%).
- 相关因素包括家庭酒精使用史,心理困扰,终身卡特使用和文凭水平的教育.
结论:
- 在卫生专业人员中,危险的酒精使用率很高,需要采取紧急干预策略.
- 解决家庭病史,心理困扰,Khat使用和教育差异对于预防和治疗至关重要.
更多相关视频
08:45Modeling Alcohol Consumption in Rodents Using Two-Bottle Choice Home Cage Drinking and Microstructural Analysis
Published on: November 8, 2024
422
05:40The Motivation for Alcohol Reward: Predictors of Progressive-Ratio Intravenous Alcohol Self-Administration in Humans
Published on: April 28, 2022
2.9K
相关概念视频
CNS Depressants: Alcohol and Nicotine
166
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
166
Stress Prevention and Stress Management Techniques IV
23
Stress often leads to unhealthy habits like smoking, excessive drinking, and overeating, which offer short-term relief but ultimately increase long-term health risks. These behaviors create a cycle that temporarily lowers stress levels but can result in severe long-term health consequences. Breaking these habits is essential to reduce the risk of chronic diseases and improve overall well-being. Three primary changes that support better health include quitting smoking, reducing alcohol intake,...
23
Pulmonary Tuberculosis I
215
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
215
Enzyme Inhibition
77.7K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
77.7K
Substance Use Disorders Affecting Sleep
152
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
152
Hazard Ratio
73
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
73
